In post‐CABG patients with mild depression, hesperidin at a dose of 200 mg/day for 12 weeks reduced the severity of depression, as compared to placebo, but it had no effect on serum BDNF and cortisol levels. The gene discussed is BDNF; the disease is major depressive disorder.